Trial intelligence / Profile preview

Methylprednisolone and Hyaluronic Acid for Postoperative Complications After Wisdom Tooth Extraction

NCT07317596Phase 3Enrolling by invitation

Sponsor
Sana'a University
Start
Jun 2024
Primary completion
Jul 2026
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone injection, hyaluronic acid sodium composite gel for injection in postoperative complications, sponsored by Sana'a University. Started Jun 2024; status: enrolling by invitation.

02

Drugs

methylprednisolone injectionhyaluronic acid sodium composite gel for injection
03

Conditions

postoperative complications

Beyond the preview

Go deeper on NCT07317596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07317596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call